Baqsimi™ (glucagon) nasal powder

3mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Has Baqsimi™ (glucagon) nasal powder been studied in patients using sulfonylureas?

The use of glucagon nasal powder in patients treated with sulfonylureas has not been studied.

US_cFAQ_NG031_USE_WITH_SULFONYLUREAS
US_cFAQ_NG031_USE_WITH_SULFONYLUREAS
en-US

Use With Sulfonylureas

The use of Baqsimi in patients treated with sulfonylureas has not been studied.

Date of Last Review: October 25, 2021


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical